Khosla Ventures is a distinguished American venture capital firm established in 2004 by Vinod Khosla, co-founder of Sun Microsystems. The firm is renowned for its investments in early-stage and growth-stage companies pioneering disruptive technologies in sectors such as internet, AI, mobile, enterprise, financial services, silicon technology, biotechnology, healthcare, and clean technology. Khosla Ventures actively seeks out 'black swan' or 'sci-fi' ideas—technologies with low probabilities but potentially massive societal and economic impact. They offer venture assistance, strategic guidance, and operational support to entrepreneurs aiming to build impactful, world-changing companies.
The headquarters serves as the primary center for investment strategy, deal sourcing and execution, portfolio company management, and engagement with the broader technology and investment ecosystem.
Located on the iconic Sand Hill Road, a prestigious address synonymous with venture capital. The office environment is designed to foster collaboration and innovation, likely featuring modern, open workspaces and advanced meeting facilities.
The work culture at Khosla Ventures is characterized by intellectual rigor, a fast-paced environment, and a focus on bold, contrarian thinking. There's a strong emphasis on deep technological understanding, supporting visionary founders, and a hands-on approach to helping portfolio companies succeed.
Its Menlo Park location provides Khosla Ventures with unparalleled access to a dense network of entrepreneurs, technologists, research institutions, and co-investors, crucial for identifying and nurturing groundbreaking ventures.
Khosla Ventures maintains a significant global presence through its diverse investment portfolio spanning North America, Europe, Asia, and other emerging innovation hubs. While its operational headquarters is in Silicon Valley, the firm actively sources, invests in, and supports pioneering companies worldwide. Globally supported functions include investment identification, due diligence on international opportunities, fostering strategic partnerships, and providing mentorship and resources to help international portfolio companies scale and achieve global market leadership.
2121 Sand Hill Road, Suite 100
Menlo Park
CA
USA
Address: N/A (No single fixed public address for a secondary office)
To extend the firm's reach, identify investment opportunities, and provide localized support and insights in key international markets and tech ecosystems where Khosla Ventures actively invests or has portfolio companies.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Khosla Ventures' leadership includes:
Khosla Ventures has been backed by several prominent investors over the years, including:
Khosla Ventures generally maintains a stable senior leadership team. Public announcements of executive partner-level hires or departures are infrequent. Based on available public information from the last 12 months (approx. June 2023 - June 2024), no major widely publicized executive hires or exits at the Managing Director/General Partner level have been identified.
Discover the tools Khosla Ventures uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Khosla Ventures typically utilizes a standard email format, most commonly [first_initial][last_name]@khoslaventures.com. While variations may exist for some individuals, this pattern is widely observed for communications with the firm.
flast@khoslaventures.com
Format
vkhosla@khoslaventures.com
Example
80%
Success rate
TechCrunch • May 23, 2024
Lyzr, a startup developing generative AI-powered 'agents' for enterprise applications, announced it has raised $4 million in a seed funding round led by Khosla Ventures. The funding will be used to expand its R&D and go-to-market efforts....more
PR Newswire • May 21, 2024
Alumis Inc., a clinical-stage biopharmaceutical company developing oral therapies to address immune dysfunction, announced the closing of an upsized $219 million Series C financing. Khosla Ventures participated in the round, which will support the advancement of Alumis' pipeline of precision immunology therapies....more
Business Wire • April 18, 2024
Khosla Ventures announced the closing of new funds totaling over $3 billion. These funds will be dedicated to investing in both early-stage and growth-stage companies, with a continued focus on impactful innovations across various sectors including AI, sustainability, and healthcare....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Khosla Ventures, are just a search away.